Continuous glucose monitoring (CGM) is recommended for many people with diabetes [1,2], including those with type 1 diabetes, type 2 diabetes treated with insulin, and type 2 diabetes treated with noninsulin regimens. This evidence concerns the gene INS and type 2 diabetes mellitus.